Flerie Competitors and Similar CompaniesClear all
Flerie's competitors and similar companies include Biogen and Alembic Pharmaceuticals.
 Flerie Flerie (formerly known as InDex Pharmaceuticals Holding) is a investment company that focuses on the life sciences sector. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 2000 | Founding Date 1978 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Solna, SE HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN |
Employees | Employees 8 | Employees 7,605 | Employees 14,858 |
Valuation ($) | Valuation ($) 350.9 m | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit kr10.9m (FY, 2025) | Gross profit $7.5b (FY, 2025) | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income (kr756.9m) (FY, 2025) | Net income $1.3b (FY, 2025) | Net income ₹6.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company